Medicinal product name Oprymea
Pharmaceutical form Tablet
Strength 0.35 mg 
Information from the MAH on shortages Not notified
Legal status Rx Prescription (Pr.)
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code N04BC05 Anti-parkinson drugs

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N20
(0,35 mg)
Al/Al blister    EU/1/08/469/011  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/08/469/011
Date of authorisation Sep 12, 2008
Marketing authorisation holder, country KRKA, d.d., Novo mesto, Slovenia